Based on this close and complex relationship between immune inflammation and inflammation-induced cell cycle activation and cancer, inflammatory factors and pathways can be as potential targets in combination with HSV-TK/GCV suicide gene therapy in antitumor therapy. The gene discussed is TKT; the disease is cancer.